GABA AGONISTS AND UPTAKE INHIBITORS - SYNTHESIS, ABSOLUTE STEREOCHEMISTRY, AND ENANTIOSELECTIVITY OF (R)-(-)-HOMO-BETA-PROLINE AND (S)-(+)-HOMO-BETA-PROLINE

被引:65
作者
NIELSEN, L [1 ]
BREHM, L [1 ]
KROGSGAARDLARSEN, P [1 ]
机构
[1] ROYAL DANISH SCH PHARM,PHARMABIOTEC RES CTR,DEPT ORGAN CHEM,2 UNIV PK,DK-2100 COPENHAGEN,DENMARK
关键词
D O I
10.1021/jm00163a012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cyclic analogue of 4-aminobutyric acid (GABA), 3-pyrrolidineacetic acid (homo-β-proline), is a potent agonist at GABAAreceptors, it interacts effectively with GABA-uptake mechanisms, and it is a moderately potent inhibitor of GABABreceptor binding. (R)-(-)-(10) and (S)-(+)-homo-β-proline (15) were synthesized via methyl (3S)-1-[(R)-1-phenylethyl]-5-oxo-3-pyrrolidinecarboxylate (5) and its 3R diastereomer (4), respectively. The mixture 3 consisting of 4 and 5 was synthesized via addition-cyclization reactions between (R)-1-phenylethylamine and itaconic acid (1). The diastereomers 5 and 4, which were separated chromatographically, were converted into (R)-(10) and (S)-homo-β-proline (15), respectively. The absolute stereochemistry of 10 and 15 was established on the basis of an X-ray analysis of compound 5. The enantiomers 10 and 15 were shown to bind to GABAAand GABABreceptor sites with opposite stereoselectivity. Thus, (β)-homo-β-proline (10) proved to be more than 1 order of magnitude more potent than the S enantiomer (15) as an inhibitor of GABAAreceptor binding, whereas the GABABreceptor affinity of homo-β-proline was shown to reside exclusively in (S)-homo-β-proline (15). In contrast to the stereoselective receptor affinities of 10 and 15, these enantiomers were approximately equieffective as inhibitors of synaptosomal GABA uptake. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 43 条
[1]   ORALLY ACTIVE AND POTENT INHIBITORS OF GAMMA-AMINOBUTYRIC ACID UPTAKE [J].
ALI, FE ;
BONDINELL, WE ;
DANDRIDGE, PA ;
FRAZEE, JS ;
GARVEY, E ;
GIRARD, GR ;
KAISER, C ;
KU, TW ;
LAFFERTY, JJ ;
MOONSAMMY, GI ;
OH, HJ ;
RUSH, JA ;
SETLER, PE ;
STRINGER, OD ;
VENSLAVSKY, JW ;
VOLPE, BW ;
YUNGER, LM ;
ZIRKLE, CL .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (05) :653-660
[2]   SYNTHETIC ANALOGS FOR THE STUDY OF GABA AS A NEUROTRANSMITTER [J].
ALLAN, RD ;
JOHNSTON, GAR .
MEDICINAL RESEARCH REVIEWS, 1983, 3 (02) :91-118
[3]  
AVOLI M, 1988, NEUROTRANSMITTERS CO, P187
[4]  
CHASE TN, 1979, HUNTINGTONS DISEASE
[5]  
CURTIS DR, 1974, ERG PHYSIOL BIOL CH, V69, P97
[6]  
DEFEUDIS F V, 1981, Neurochemistry International, V3, P113, DOI 10.1016/0197-0186(81)90029-2
[7]   GABA RECEPTOR PHARMACOLOGY - FUNCTIONAL CONSIDERATIONS [J].
ENNA, SJ .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (09) :907-913
[8]   PROPERTIES OF GAMMA-AMINOBUTYRIC ACID (GABA) RECEPTOR-BINDING IN RAT-BRAIN SYNAPTIC MEMBRANE-FRACTIONS [J].
ENNA, SJ ;
SNYDER, SH .
BRAIN RESEARCH, 1975, 100 (01) :81-97
[9]  
Enna SJ, 1983, GABA RECEPTORS
[10]  
FALCH E, 1986, J NEUROCHEM, V47, P898